Publication details

Použití esmololu v léčbě paroxysmální fibrilace síní u nemocné se subklinickou hyperthyreozou

Title in English Esmolol in the treatment of paroxysmal atrial fibrilation in patient with subclinic hypertherosis
Authors

ŠPÁC Jiří BALŠÍKOVÁ Karola

Year of publication 2012
Type Article in Periodical
Magazine / Source Farmakoterapie
Citation
Keywords esmolol, hyperthyreosis
Description Prevalence of atrial fibrillation and supraventricular tachycardia in patients with hyperthyroidism is from 2-20%, and its incidence increases with age. Mild and subclinical forms of hyperthyroidism have the same relative risk of atrial fibrillation as a developed form. Ultra-short-acting beta blocker esmolol is a suitable product for the treatment of fibrillation in patients with hyperthyroidism

You are running an old browser version. We recommend updating your browser to its latest version.

More info